al-Dhalimy M - Search Results

1

Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Grompe M, Overturf K, al-Dhalimy M, Finegold M. Grompe M, et al. J Inherit Metab Dis. 1998 Aug;21(5):518-31. doi: 10.1023/a:1005462804271. J Inherit Metab Dis. 1998. PMID: 9728332

2

Nucleotide sequence of a cDNA encoding murine fumarylacetoacetate hydrolase.

Grompe M, al-Dhalimy M. Grompe M, et al. Biochem Med Metab Biol. 1992 Aug;48(1):26-31. doi: 10.1016/0885-4505(92)90044-y. Biochem Med Metab Biol. 1992. PMID: 1524868

3

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.

Grompe M, Lindstedt S, al-Dhalimy M, Kennaway NG, Papaconstantinou J, Torres-Ramos CA, Ou CN, Finegold M. Grompe M, et al. Nat Genet. 1995 Aug;10(4):453-60. doi: 10.1038/ng0895-453. Nat Genet. 1995. PMID: 7545495

4

Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.

Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou CN, Finegold M, Grompe M. Overturf K, et al. Nat Genet. 1996 Mar;12(3):266-73. doi: 10.1038/ng0396-266. Nat Genet. 1996. PMID: 8589717

5

Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.

Overturf K, al-Dhalimy M, Ou CN, Finegold M, Tanguay R, Lieber A, Kay M, Grompe M. Overturf K, et al. Hum Gene Ther. 1997 Mar 20;8(5):513-21. doi: 10.1089/hum.1997.8.5-513. Hum Gene Ther. 1997. PMID: 9095403

6

Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.

Overturf K, Al-Dhalimy M, Manning K, Ou CN, Finegold M, Grompe M. Overturf K, et al. Hum Gene Ther. 1998 Feb 10;9(3):295-304. doi: 10.1089/hum.1998.9.3-295. Hum Gene Ther. 1998. PMID: 9508047

7

In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.

Manning K, Al-Dhalimy M, Finegold M, Grompe M. Manning K, et al. Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11928-33. doi: 10.1073/pnas.96.21.11928. Proc Natl Acad Sci U S A. 1999. PMID: 10518553 Free PMC article.

8

Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.

Al-Dhalimy M, Overturf K, Finegold M, Grompe M. Al-Dhalimy M, et al. Mol Genet Metab. 2002 Jan;75(1):38-45. doi: 10.1006/mgme.2001.3266. Mol Genet Metab. 2002. PMID: 11825062

9

A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.

Grompe M, St-Louis M, Demers SI, al-Dhalimy M, Leclerc B, Tanguay RM. Grompe M, et al. N Engl J Med. 1994 Aug 11;331(6):353-7. doi: 10.1056/NEJM199408113310603. N Engl J Med. 1994. PMID: 8028615 Free article.

10

Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.

Grompe M, al-Dhalimy M, Finegold M, Ou CN, Burlingame T, Kennaway NG, Soriano P. Grompe M, et al. Genes Dev. 1993 Dec;7(12A):2298-307. doi: 10.1101/gad.7.12a.2298. Genes Dev. 1993. PMID: 8253378 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters